These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


234 related items for PubMed ID: 27501504

  • 21. A retrospective review of metronidazole and vancomycin in the management of Clostridium difficile infection in patients with hematologic malignancies.
    Parmar SR, Bhatt V, Yang J, Zhang Q, Schuster M.
    J Oncol Pharm Pract; 2014 Jun; 20(3):172-82. PubMed ID: 23804627
    [Abstract] [Full Text] [Related]

  • 22. Evaluation of Risk Factors for Clostridium difficile Infection in Hematopoietic Stem Cell Transplant Recipients.
    Scardina TL, Kang Martinez E, Balasubramanian N, Fox-Geiman M, Smith SE, Parada JP.
    Pharmacotherapy; 2017 Apr; 37(4):420-428. PubMed ID: 28226419
    [Abstract] [Full Text] [Related]

  • 23. Diarrhoea caused by Clostridium difficile: response time for treatment with metronidazole and vancomycin.
    Wilcox MH, Howe R.
    J Antimicrob Chemother; 1995 Oct; 36(4):673-9. PubMed ID: 8591942
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. High frequency of nonadherence to Clostridium difficile treatment guidelines.
    McEllistrem MC, McGraw M, Sahud AG, Chan-Tompkins NH, Goswami R, Bhanot N.
    South Med J; 2014 Sep; 107(9):597-9. PubMed ID: 25188627
    [Abstract] [Full Text] [Related]

  • 29. Risk of Clostridium difficile infection in hospitalized patients receiving metronidazole for a non-C difficile infection.
    Rodriguez S, Hernandez MB, Tarchini G, Zaleski M, Vatanchi M, Cardona L, Castro-Pavia F, Schneider A.
    Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1856-61. PubMed ID: 24681079
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The Rise and Fall of Metronidazole for Clostridium difficile Infection.
    Chahine EB.
    Ann Pharmacother; 2018 Jun; 52(6):600-602. PubMed ID: 29424238
    [Abstract] [Full Text] [Related]

  • 32. Cost-effectiveness analysis of treatment strategies for initial Clostridium difficile infection.
    Varier RU, Biltaji E, Smith KJ, Roberts MS, Jensen MK, LaFleur J, Nelson RE.
    Clin Microbiol Infect; 2014 Dec; 20(12):1343-51. PubMed ID: 25366338
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea.
    Bishara J, Wattad M, Paul M.
    Clin Infect Dis; 2007 Dec 15; 45(12):1646-7; author reply 1649-51. PubMed ID: 18190329
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Real-time polymerase chain reaction testing for Clostridium difficile reduces isolation time and improves patient management in a small community hospital.
    Catanzaro M, Cirone J.
    Am J Infect Control; 2012 Sep 15; 40(7):663-6. PubMed ID: 22153847
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Vancomycin therapy for severe Clostridium difficile-associated diarrhea.
    Huggan PJ, Murdoch DR.
    Clin Infect Dis; 2007 Dec 15; 45(12):1647-8; author reply 1649-51. PubMed ID: 18190330
    [No Abstract] [Full Text] [Related]

  • 39. Antimicrobial prescribing practices in response to different Clostridium difficile diagnostic methodologies.
    Sydnor ER, Lenhart A, Trollinger B, Avdic E, Maragakis LL, Carroll KC, Cosgrove SE.
    Infect Control Hosp Epidemiol; 2011 Nov 15; 32(11):1133-6. PubMed ID: 22011545
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 12.